news Efficacy of iclaprim confirmed in independent laboratory study 24 August 2015 | By Victoria White Motif Bio has announced the topline results of an independent report that show iclaprim is effective in vitro against a range of Gram-positive bacteria...
news Motif Bio announces intention to float on AIM 3 February 2015 | By Motif Bio Motif Bio plc is seeking to raise at least £4 million through a placing of new ordinary shares and admission to trading on AIM...